ATEC vs the Competition: Which Stock Comes Out on Top?
Here is how Alphatec (ATEC) stacks up against its peers in size, valuation, growth and margin.
- ATEC’s operating margin of -13.9% is negative, and lower than most peers – trailing MTD (28.7%).
- ATEC’s revenue growth of 26.3% in the last 12 months is strong, outpacing A, PBIO, CERS, TECH, MTD.
- ATEC gained 152.8% in the past year and trades at a PE of -14.3, outperforming its peers.
As a quick background, Alphatec provides advanced surgical technologies for spinal disorder treatment, distributing products through independent distributors and direct sales representatives across the United States.
| ATEC | A | PBIO | CERS | TECH | MTD | |
|---|---|---|---|---|---|---|
| Market Cap ($ Bil) | 2.4 | 34.3 | 0.0 | 0.2 | 8.6 | 27.6 |
| Revenue ($ Bil) | 0.7 | 6.6 | 0.0 | 0.2 | 1.2 | 3.8 |
| PE Ratio | -14.3 | 29.4 | -0.0 | -13.1 | 65.4 | 32.5 |
| LTM Revenue Growth | 26.3% | 0.6% | -25.3% | 13.3% | 4.7% | 1.2% |
| LTM Operating Margin | -13.9% | 21.4% | -547.8% | -6.1% | 17.2% | 28.7% |
| LTM FCF Margin | -4.6% | 17.9% | -296.3% | 1.8% | 18.3% | 22.7% |
| 12M Market Return | 152.8% | -11.9% | -99.6% | -38.3% | -25.8% | -6.3% |
Why does this matter? ATEC just went up 46.5% in a month – peer comparison puts stock performance, valuation, and financials in context – highlighting whether it is truly outperforming, lagging behind, and above all – can this continue? Read Buy or Sell ATEC Stock to see if Alphatec holds up as a quality investment. Furthermore, there is always a risk of fall after a strong rally – see how the stock has dipped and recovered in the past through ATEC Dip Buyer Analysis lens.
While peer comparison is critical Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risks while giving upside exposure.
Revenue Growth Comparison
| LTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| ATEC | 26.3% | 26.8% | 37.4% | 44.3% | |
| A | 0.6% | -4.7% | -0.2% | 8.4% | |
| PBIO | -25.3% | – | 14.4% | -13.6% | 64.0% |
| CERS | 13.3% | 15.3% | -3.5% | 23.8% | |
| TECH | 4.7% | 2.0% | 2.8% | 18.7% | |
| MTD | 1.2% | 2.2% | -3.4% | 5.4% |
Operating Margin Comparison
| LTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| ATEC | -13.9% | -20.1% | -30.7% | -34.5% | |
| A | 21.4% | 22.9% | 19.8% | 23.6% | |
| PBIO | -547.8% | – | -480.5% | -283.2% | -209.0% |
| CERS | -6.1% | -7.9% | -16.8% | -21.0% | |
| TECH | 17.2% | 21.0% | 25.6% | 26.8% | |
| MTD | 28.7% | 29.1% | 28.5% | 28.7% |
PE Ratio Comparison
| LTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| ATEC | -10.0 | -8.1 | -9.8 | -8.4 | |
| A | 28.6 | 30.2 | 33.0 | 35.7 | |
| PBIO | -0.0 | – | -0.0 | -0.2 | -0.4 |
| CERS | -14.3 | -13.6 | -10.4 | -15.1 | |
| TECH | 70.1 | 67.6 | 42.5 | 47.8 | |
| MTD | 28.9 | 30.1 | 33.6 | 37.3 |
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.